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Abstract
Masao Matsuoka wins the 2011 Retrovirology Prize.
Seven years ago, Retrovirology inaugurated an annual
prize to recognize the achievements of a deserving ret-
rovirologist [1]. The Prize was founded by the Ming K.
Jeang Foundation, a philanthropic charity based in
Houston, Texas, which has provided scholarships at
Houston schools, the University of Arizona, and the
Johns Hopkins University School of Medicine. Previous
winners of the Retrovirology Prize include Stephen Goff,
Joseph Sodroski, Karen Beemon, Ben Berkout, Thierry
Heidmann [2], and Michael Malim [3]. Annually, the
Retrovirology Prize recognizes an outstanding mid-career
scientist who is at the height of his/her scientific pro-
ductivity and who is expected to have many future years
of high achievement. In even numbered years, the Prize
is awarded to an HIV virologist, in odd numbered years
it is for a non-HIV retrovirologist.
For 2011, the Editors of Retrovirology have selected
Masao Matsuoka as the recipient of the Retrovirology
Prize (Figure 1). Professor Masao Matsuoka is a physi-
cian by training and an oncologist by medical specialty.
He graduated from Kumamoto University School of
Medicine and did a postdoctoral fellowship at the Uni-
v e r s i t yo fC a l i f o r n i aB e r k e l e yb e f o r er e t u r n i n gt oJ a p a n
w h e r eh ec u r r e n t l yi st h eP r o f e s s o ra n dD i r e c t o ro ft h e
Institute for Virus Research at Kyoto University. For the
past 25 years, Matsuoka has been a pioneer and a lead-
ing figure in human T-cell leukemia virus type 1
(HTLV-1) research. He has made many important dis-
coveries with two particularly notable findings. HTLV-1
infection frequently becomes latent, and one of the
major puzzles in the field is how this occurs. Matsuoka’s
seminal contribution here is his discovery that the 5’
LTR DNA sequence of the HTLV-1 provirus is prefer-
entially methylated while the 3’ LTR of the provirus is
not. His work in this area is independent of and con-
temporaneous with similar observations made in human
immunodeficiency virus type 1 (HIV-1) research and
has added to our insights on how retroviral latency is
achieved and how it might be thwarted by employing
targeted therapeutic agents.
Because Matsuoka found that the 3’ LTR of the
HTLV-1 provirus is surprisingly hypomethylated, this
led him to consider whether such a state would favor an
antisense transcript originating from this end of the pro-
viral genome. HIV-1 researchers have long ago dis-
counted the importance of a 3’ LTR driven antisense
transcript. Yet, in the last decade, independent results
from Mesnard (France) and Matsuoka (Japan) have
strongly established the existence and biological impor-
tance of an HTLV-1 antisense transcript called HBZ.
The HBZ RNA encoded by the minus strand of the pro-
virus is capable of encoding a bZIP protein, and Mat-
suoka and his colleagues have shown that this RNA and
its protein are expressed in all Adult T-cell leukemias
(ATLs). Importantly, Matsuoka is the first to demon-
strate that the expression of HBZ promotes the prolif-
eration of T cells, and he has reported that HBZ
expressing transgenic mice develop T cell lymphomas.
Professor Matsuoka has been a founding member of
Retrovirology’s editorial board. To understand better
Masao’sv i e w s ,Ia s k e df o rh i sa n s w e r st os e v e r a l
questions.
KTJ: Tell me what you find the most rewarding about
being a retrovirologist?
MM: Human retroviruses are big threats to humans.
They evolve to replicate elaborately in human cells
using their small genomes. Whenever I find clever
mechanisms of retroviruses, they never failed to surprise
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them from humans and to prevent retroviral diseases.
As a retrovirologist, I am fascinated to study these
small, but immensely important genomes with their
ingenious mechanisms.
KTJ: Did you ever have second thoughts about being
a scientist? What would you have done if you did not
become a scientist?
MM: When I was a boy, I was fascinated with living
fish and insects. I was very much interested in living
animals. It is a reason that I love fishing. If I did not
become a scientist, I would have liked to be a fisherman.
However, for Japanese fishermen, it is very competitive
to catch good fish for “Sushi”. I am skeptical that I can
succeed as a fisherman. I guess that being a scientist is
better for me.
KTJ: The 21
st century is said by many to be the “Paci-
fic century”—how do you see science being different in
the 21
st century compared to the 20
th century?
MM: I am confident in the 21
st century that people in
the Pacific countries will be influential in science. A
striking feature of this region is diversity in many
aspects, including race, culture, politics, and so on. I
hope that this huge diversity generates new science, and
contributes to human society to solve many challenging
puzzles like climate changes, and ever changing diseases
(diabetes mellitus, cancer, infectious diseases, etc.), and
the exhaustion of natural resources. Of course, none of
these issues are easy to be solved. I really hope that
diverse people in Pacific countries contribute to these
tough problems.
KTJ: Young scientists face many obstacles today in
developing their careers — what do you see as some
obstacles facing young Japanese scientists and how
would you advise them?
MM: In most Japanese universities, associate and
assistant professors work under the supervision of full
professors. Full professors get grant money from the
government or funding agencies, and they usually deter-
mine the research theme for young scientists. It is not
an actual independent position. I would like to recom-
mend young scientists to be independent as possible as
they can or to choose a good boss who permits them to
do independent research.
KTJ: Someone told me once that every 10 years he
reinvents himself. What do you see yourself doing 10
years from now that might be different from what you
are doing today?
MM: I agree that reinventing oneself is a nice and
cool idea. However, I think that people (except rare per-
sons) tend to behave as they always are. Before I moved
to this Institute, I was a clinician, and took care of
many patients in the hospital. I spent small efforts for
my research at that time (half clinician, and half scien-
tist). However, now I spend much more time for my
research in Institute for Virus Research, Kyoto Univer-
sity. My past background is good experience for me
since I can appreciate different points of view for retro-
virology. Actually, I think understanding how the virus
induces various clinical conditions (inflammation, hyper-
calcemia, immunodeficiency, etc.) from virological and
clinical points of view provide informed and synergistic
Figure 1 A picture of the Retrovirology Prize trophy (left) and Masao Matsuoka (right).
Jeang Retrovirology 2011, 8:102
http://www.retrovirology.com/content/8/1/102
Page 2 of 3perspectives. Sometimes, these different views lead to
new ideas.
KTJ: You have published 6 papers [4-9] in Retrovirol-
ogy — tell me what do you think about Open Access —
should this principle be important to Japanese scientists,
why or why not?
MM: I strongly agree with Open Access. Access to
knowledge should be open to anyone who wants it.
Recently, Japanese government and funding agencies do
not request open access to scientists. This policy should
be changed. Kyoto University has its own repository
(Kyoto University Research Information Repository),
Kurenai (that means “truly red” in Japanese), to access
publications from Kyoto University. The world is some-
times unfair. But, science should be open and fair for
anyone who wants to know new findings and knowl-
edge. It should be the concrete basis for science.
KTJ: When the time comes and you retire from doing
science, how and for what would you like to be
remembered?
MM: When I retire from science, I would like to be
remembered as a researcher who connected clinical
science and retrovirology. Of course, I also study drug
development for HIV-1 and resistance mechanisms. I
am confident that there are many other important con-
tributors to this field of HIV.
KTJ: Finally, if you have an opportunity to address a
gathering of all the world leaders at the United Nation,
in 250 words or less — what would you say to them?
MM: Now, the world has become closely connected
more than at any other time of human history in many
aspects. Economies are tightly linked, and an economical
crisis like the Greek crisis in one country quickly affects
many other world economies. Climate changes also
influence the world. In the latter, a limitless desire of
human exploitation of our environment has exacerbated
these situations. A new viral infection quickly spreads
within weeks like SARS. The HIV pandemic is a big tra-
gedy to human, and avian influenza will be a new threat.
To respond to these infections, we need a new platform
of collaboration and friendship. Thus, we must appreci-
ate that people and countries are indivisibly united.
However, the sad thing is that people of the world are
stuck in old thinking. We need to understand that in
today’s world it is not possible for one country to pur-
sue mainly its own benefit.
The “chyu-you (derived from the famous Chinese
book)” means the balanced state or person with harmo-
nized character, which is appreciated by people for a
long time in Japan. I hope that people and countries
should keep this word in mind, and exercise control
over themselve. The host and the pathogen co-evolve to
adapt to each other. It is time for humans to harmonize
the world and society. Science is an important arena
which gives us many opportunities to achieve this.
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